Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-3.330%
-0.04
-3.330%
-
 
03.06.26 / Frankfurt WKN: A1JLYP / Name: CMS / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for CMS

sharewise wants to provide you with the best news and tools for CMS, so we directly link to the best financial data sources.

News

Addus HomeCare Says License Moratorium Won’t Slow Personal Care Growth, M&A
Addus HomeCare Says License Moratorium Won’t Slow Personal Care Growth, M&A

Key Points

GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead

GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related

DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport
DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport

DocGo (NASDAQ:DCGO) Chief Executive Officer Lee Bienstock outlined the company’s transition away from COVID-related, migrant and emergency-response

BioStem Technologies Q1 Earnings Call Highlights
BioStem Technologies Q1 Earnings Call Highlights

BioStem Technologies (OTCMKTS:BSEM) said its first quarter of 2026 marked a major shift in its business model following a late-January acquisition that moved the company’s focus from physician

Aveanna Healthcare Q1 Earnings Call Highlights
Aveanna Healthcare Q1 Earnings Call Highlights

Aveanna Healthcare (NASDAQ:AVAH) raised its full-year 2026 outlook after reporting double-digit revenue and adjusted EBITDA growth in the first quarter, citing improved reimbursement rates, higher

Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations

Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected

Nyxoah Q1 Earnings Call Highlights
Nyxoah Q1 Earnings Call Highlights

Nyxoah (NASDAQ:NYXH) reported 13% sequential worldwide net revenue growth in the first quarter of 2026, driven primarily by continued adoption of its Genio system in the United States, where the

Fractyl Health Q1 Earnings Call Highlights
Fractyl Health Q1 Earnings Call Highlights

Fractyl Health (NASDAQ:GUTS) said it remains on track to report pivotal data for its Revita therapy in early fourth quarter 2026, as management highlighted clinical, regulatory and reimbursement

SiBone Q1 Earnings Call Highlights
SiBone Q1 Earnings Call Highlights

SiBone (NASDAQ:SIBN) raised its full-year 2026 outlook after reporting double-digit revenue growth in the first quarter, with management

OPAL Fuels Q1 Earnings Call Highlights
OPAL Fuels Q1 Earnings Call Highlights

OPAL Fuels (NASDAQ:OPAL) said it remains on track to meet its full-year 2026 guidance despite lower first-quarter revenue and adjusted

CareTrust REIT Q1 Earnings Call Highlights
CareTrust REIT Q1 Earnings Call Highlights

CareTrust REIT (NYSE:CTRE) reported a strong start to 2026, highlighting rapid investment activity, higher funds from operations and an increased full-year outlook during its first-quarter earnings

Oncology Institute Q1 Earnings Call Highlights
Oncology Institute Q1 Earnings Call Highlights

Oncology Institute (NASDAQ:TOI) reported a strong start to 2026, with first-quarter revenue rising 41% year over year as the company expanded value-based care arrangements and posted record

Privia Health Group Q1 Earnings Call Highlights
Privia Health Group Q1 Earnings Call Highlights

Privia Health Group (NASDAQ:PRVA) reported a strong first quarter, with executives pointing to double-digit provider growth, a larger value-based care population and margin expansion as signs that

Organogenesis Q1 Earnings Call Highlights
Organogenesis Q1 Earnings Call Highlights

Organogenesis (NASDAQ:ORGO) reported a sharp year-over-year revenue decline in the first quarter of 2026, with executives pointing to significant disruption in the skin substitute market following

DTE’s Stargate Deal Turns Power Into Profits
DTE’s Stargate Deal Turns Power Into Profits

The financial landscape of early 2026 has been defined by a singular, violent theme: rotation. As investors flee the speculative froth of the technology sector, capital is finding a new home in

CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing.: https://g.foolcdn.com/editorial/images/864520/medicare-enrollment-form-healthcare-insurance-1201x798-36b7a2e.jpg
CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing.

In a matter of months, a key issue affecting CVS Health's (NYSE: CVS) performance has seemingly vanished. On April 7, the Centers for Medicare & Medicaid Services (CMS) finalized the amount by which

Medicare Is Making a Major Change to Expand Coverage as Early as April: https://g.foolcdn.com/editorial/images/860079/doctor-talking-with-patient.jpg
Medicare Is Making a Major Change to Expand Coverage as Early as April

Close to 70 million seniors are covered by Medicare across the United States, according to the Centers for Medicare and Medicaid Services (CMS). Those covered seniors may soon find themselves

New Rules Says Medicare Advantage Can't Cover These Treatments More Seniors Rely On
New Rules Says Medicare Advantage Can't Cover These Treatments More Seniors Rely On

Since 2018, Medicare Advantage Plans have had flexibility in what they cover, as the Bipartisan Budget Act of 2018 allowed plans to expand coverage to include Special Supplemental Benefits for the

New Medicare Advantage Rule Forbids Coverage of Procedures Used by Over 4 Million Seniors
New Medicare Advantage Rule Forbids Coverage of Procedures Used by Over 4 Million Seniors

Medicare Advantage plans are an alternative to traditional Medicare that can provide coverage for more services. The Bipartisan Budget Act of 2018 allowed Advantage Plans to cover things that were

Kontent.ai Appoints Mark Greenaway as CEO to Drive the Next Phase of AI in Enterprise Content
Kontent.ai Appoints Mark Greenaway as CEO to Drive the Next Phase of AI in Enterprise Content

 

 

BRNO, CZ / ACCESS Newswire / April 27, 2026 / Kontent.ai has appointed Mark Greenaway as Chief Executive Officer, as the company looks to scale its Agentic CMS and transform content